Pulmonary hypertension (PH) has a high mortality rate if untreated. Unfortunately, the disease is not consistently diagnosed or treated across the United States. To improve the diagnosis and care of ...

Pulmonary hypertension life expectancy and prognosis can vary broadly, but have improved in the era of modern treatment.

Please provide your email address to receive an email when new articles are posted on . Among pediatric patients in the Pediatric Pulmonary Hypertension Network, nearly half had group 3 disease, ...

Pulmonary hypertension, simply put, is high blood pressure in the arteries that supply the lungs. You may assume that if you have been diagnosed with hypertension – high blood pressure – then it would ...

Panelists discuss how pulmonary arterial hypertension diagnosis requires comprehensive evaluation including right heart catheterization to confirm hemodynamic criteria, with normal mean PA pressure ...

Winrevair, also known as sotatercept-csrk, is a medicine used to treat pulmonary arterial hypertension (PAH), which causes high blood pressure in the arteries that go from your heart to your lungs.

In ‘Made in SG’ Melanie Oliveiro profiles the locally founded Pulmonary Hypertension Support Group (PHSG), a patient support ...

In patients with pulmonary arterial hypertension (PAH), the use of anticoagulants was not associated with improvement in overall survival, and these results were confirmed by an updated meta-analysis.